Sephora: read the Global Privacy Control signal and stop the trackers it covers
AnnouncedStage: Settlement announced
USD 1,200,000Civil penalties
Ignored opt-out signals, US
California DOJ, California, US
California DOJ source (opens in a new tab)Check two things in every ad request: that it does not fire after an opt-out, and that its page title or URL does not say something sensitive about the reader. California's Healthline case alleged both failures, and ended with what the Attorney General called a "novel term": a ban on sharing certain article titles with an identifier.
Healthline stipulated without admitting liability and without any adjudication of fact or law (Judgment, pp. 1–2).
About 6.5 million Californians a month read Healthline.com without logging in (Complaint, ¶ 8). The Attorney General alleged that after a reader opted out by every available route, ad trackers kept sending their identifier together with titles such as "Newly Diagnosed with HIV? Important Things to Know" to advertising companies. About 65,000 Californians had opted out, mostly through Global Privacy Control (Complaint, ¶¶ 1, 14, 21).
| Claim | What the law requires | Facts alleged | Result |
|---|---|---|---|
| Selling and sharing after opt-out | Stop selling and sharing once a consumer opts out, including by GPC (Civ. Code §§ 1798.120, 1798.135) | After a "triple opt-out" (webform, GPC and unticking advertising cookies), investigators found 118 third-party advertising cookies, 82 ad tags on one page, a cookie-sync pixel and a universal ID in local storage (Complaint, ¶¶ 14–18) | Settled; not decided |
| Purpose limitation | Use data only for purposes consistent with the consumer's reasonable expectations (Civ. Code § 1798.100(c); 11 CCR § 7002) | Article titles suggesting a current diagnosis went to advertisers; the privacy policy never mentioned sharing titles (Complaint, ¶¶ 21–23) | Settled; not decided |
| Missing contract terms | Contracts with recipients must list limited, specified purposes (Civ. Code § 1798.100(d)) | Several recipients had not signed the industry framework Healthline relied on; some contracts allowed use for "any business purpose" (Complaint, ¶¶ 24–25) | Settled; not decided |
| Deceptive banner (UCL) | No misleading practices | The cookie banner let readers untick advertising cookies, but did not disable them (Complaint, ¶¶ 13, 33) | Settled; not decided |
The complaint also argued Healthline could not use the CCPA safe harbour for passing on opt-outs. It sent the US Privacy String in some traffic, but its contracts did not oblige recipients to honor it (Complaint, ¶¶ 26–27).
Paragraphs are from the signed judgment.
Healthline told the Attorney General that one opt-out mechanism was misconfigured, that ad vendors had installed some of the tags, and that its privacy compliance vendor "may not have properly identified and blocked all relevant online trackers" after detecting an opt-out. It now disables trackers directly (Complaint, ¶ 28).
Inth's technical interpretation: two separate faults. First, the opt-out was a signal passed along (the privacy string) rather than a gate: tags still loaded and decided for themselves. Second, the bid request carried document.title and the full URL by default, so the page's subject travelled with the reader's ID. Ad tags that load other tags make the first fault worse, because the blocking list never sees them.
// Bad: tags load after opt-out and carry the article title with the ID
loadAdTags();
requestAds({
uid: readCookie("uid"),
page_title: document.title, // "Newly diagnosed with ..."
page_url: location.href,
us_privacy: optedOut ? "1YYN" : "1YNN", // a signal, not a block
});
| Date | Event |
|---|---|
| Autumn 2023 | Attorney General tests Healthline's opt-outs (Complaint, ¶ 2) |
| 1 July 2025 | Complaint filed; settlement announced (Announcement) |
| 28 July 2025 | Judge Wong signs final judgment; filed the same day (Judgment, pp. 1, 8) |
Healthline pays USD 1,550,000 within 30 days after it is served with notice of entry, into the Consumer Privacy Fund (¶¶ 3, 24–25). Each side bears its own fees (¶ 26). The testing program and recipient reviews start within 180 days and run for three years, with confidential annual reports (¶¶ 21–23). The release is broad: all civil privacy and consumer protection claims about data from readers' use of Healthline's sites and apps, including for advertising and analytics (¶ 27). Nothing in the judgment is a finding.
The Attorney General billed it as the "Largest CCPA Settlement to Date" and the title ban as "a novel term" (Announcement); Disney and General Motors have since passed it. It is also an early CCPA case pleaded on purpose limitation: the claim is that the use itself, not only the missing opt-out, was unlawful. Two lessons for engineering teams: a consent vendor's blocking list is only as good as its coverage, and a contract framework counts only for recipients who actually signed it. See sensitive context in event data and CCPA.
Traces the article title from the page template into the ad request, and flags a pull request that adds an ad tag outside the consent check.
With an opt-out or GPC in place, records each request to an advertising domain, and each script injected by another script, with the page, time, region and consent state.
In California, Global Privacy Control counts as an opt-out of sale and sharing, so marketing and analytics stay off for that visitor. Inth's default California policy is opt-out, so tags run until the visitor opts out; after an opt-out the Consent banner sends it to each integration and stops loading tags that have not loaded yet. It holds back only the tags it manages; tags an ad vendor injects need Website audit to surface.
The consent record (choice, country, policy) beside the runtime observation of what loaded.
Start a free scanYour ticks stay on this page. Inth does not save or send them.
Source review: 17 October 2026. This page describes the cited records and procedural stage. It does not audit Healthline's current systems. Inth wrote the technical checks; they cannot decide which laws apply or prove compliance.